By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

VaxInnate Corporation 

300 George Street
Suite 311
New Haven  Connecticut  06511  U.S.A.
Phone: 203-785-1421 Fax: 203-785-1461


SEARCH JOBS


Industry
Biotechnology






Company News
VaxInnate Corporation Begins Phase I Clinical Trial To Evaluate Quadrivalent Vaccine For Prevention Of Seasonal Flu 3/19/2014 8:59:31 AM
VaxInnate Corporation Receives $2.1 Million From New Jersey’s Technology Business Tax Certificate Transfer Program 1/28/2014 9:40:49 AM
VaxInnate Corporation Awarded U.S. Government Grant to Develop Dengue Vaccine 4/4/2013 11:44:13 AM
VaxInnate Corporation’s License Agreement With Emergent BioSolutions (EBS) Improves U.S. Preparedness for Potential Flu Pandemics 1/16/2013 9:32:44 AM
Emergent BioSolutions (EBS) Secures Exclusive U.S. Commercial Rights to Next Generation Pandemic Influenza Vaccine Candidate 1/2/2013 9:21:54 AM
Two New Executives Join VaxInnate Corporation Management Team 9/4/2012 10:12:13 AM
VaxInnate Corporation Begins Phase I Clinical Trial to Evaluate H5N1 Vaccine Candidate for Pandemic Avian Flu 6/12/2012 10:18:26 AM
VaxInnate Corporation Names Wayne Pisano as its New CEO 4/2/2012 10:18:39 AM
VaxInnate Corporation Licenses Recombinant Flu Vaccines to CJ CheilJedang of South Korea 12/19/2011 7:00:55 AM
VaxInnate Corporation Awarded Contract by the U.S. Government To Develop Recombinant Seasonal and Pandemic Flu Vaccines 3/1/2011 10:57:17 AM
1234
//-->